Sign Out
Pregnancy risk factor C.
It is not known if fenofibrate is excreted in breast milk. Use of fenofibrate in breast-feeding mothers is contraindicated. Due to the potential for serious adverse reactions in breast-feeding infant, a decision should be made whether to discontinue breast-feeding or to discontinue this drug, taking into account the importance of treatment to the mother.
Continue with Google